Relmada Therapeutics Inc. has announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result of this acquisition, Relmada has dismissed Marcum as its independent registered public accounting firm, effective May 8, 2025, with the approval of the company's audit committee. Marcum's audit reports for fiscal years 2023 and 2024 did not contain adverse or qualified opinions, except for an explanatory note on the company's ability to continue as a going concern. Subsequently, CBIZ CPAs has been engaged as the new independent registered public accounting firm for the fiscal year ending December 31, 2025. The company noted that during the fiscal years 2023 and 2024, there were no disagreements or reportable events with Marcum concerning accounting principles, practices, or financial disclosures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.